About Biocrucible
Biocrucible, a Sapphiros group company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications.
Founded in
2021
Already working at Biocrucible?
Let’s recruit together and find your next colleague.